Concepedia

<sup>90</sup>Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

David Bushnell, Thomas M. O’Dorisio, M. Sue O’Dorisio, Yusuf Menda, Rodney J. Hicks, Eric Van Cutsem, J.-L. Baulieu, Françoise Borson‐Chazot, Lowell Anthony, Al B. Benson,

Journal of Clinical Oncology · 2010 · 303 citations · 27 references

DOIFull text

Open access

Abstract

(90)Y-edotreotide treatment improved symptoms associated with malignant carcinoid among subjects with no treatment alternatives. Treatment was well-tolerated and had an acceptable expected AE profile.

References

27

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 38.7K citations

, , +21

A 5‐decade analysis of 13,715 carcinoid tumors

Irvin M. Modlin, Kevin D. Lye, Mark Kidd · Cancer · 2003 · 2.7K citations

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 613 citations

, , +8

Updated Population-Based Review of Carcinoid Tumors

Melinda A. Maggard, Jessica B. O Connell, Clifford Y. Ko · Annals of Surgery · 2004 · 551 citations · Full text

Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center

Eva Tiensuu Janson, Lars Holmberg, Mats Stridsberg et al. · Annals of Oncology · 1997 · 458 citations

, , +8